Grant: Canada Biomedical Research Fund and Biosciences Research Infrastructure Fund
The University of British Columbia
$4,135,360.00
AVENGER: Advanced LNP RNA Vaccines Engineered with Next-Generation designs to Enhance pandemic Readiness
EF 2023-24
Programme
Canada Biomedical Research Fund and Biosciences Research Infrastructure Fund
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
SSHRC's Expenditures File
Tel que publié
Cle
9992209
File number
CBRF2-2023-00168
Name nom
Anand, Richa
Role rôle
Applicant
Amount montant
4135360.0
Fiscal year exercice financier
2023
Institution
The University of British Columbia
Établissement
The University of British Columbia
Province id
BC
Province en
British Columbia
Province fr
Colombie-Britannique
Competition year année du concours
2023
Title titre
AVENGER: Advanced LNP RNA Vaccines Engineered with Next-Generation designs to Enhance pandemic Readiness
Keywords mots clés
lipid nanoparticle; vaccine; RNA; biomanufacturing; messenger RNA; delivery platform; self-amplifying RNA
Program
Canada Biomedical Research Fund and Biosciences Research Infrastructure Fund
Programme
Fonds de recherche biomédicale du Canada et le Fonds d’infrastructure de recherche en sciences biologiques
Sshrc discipline en
Multiple primary field of research
Crsh discipline fr
Domaines de recherche principaux multiples
Sshrc main discipline
Multiple primary fields of research
Crsh discipline principale
Domaines de recherche principaux multiples
Sshrc area of research
Multiple primary socioeconomic objectives
Crsh domaine de recherche
Objectifs socioéconomiques principaux multiples
Crdc field of research
Lipid biology (including lipidomics); Applied immunology (including antibody engineering, xenotransplantation and t-cell therapies); Vaccines
Ccrd domaine de recherche
Biologie des lipides (y compris la lipidomique); Immunologie appliquée (y compris le génie des anticorps, la xénotransplantation et les thérapies cellulaires par lymphocytes T); Vaccins
